The venture capital world is buzzing today, May 1, 2026, as several significant funding rounds and strategic developments come to light. In the neurotechnology sector, Boston-based Axoft has secured $55 million in Series A funding, led by C.P. Group Innovation, with participation from Alumni Ventures, the Stanford President's Venture Fund, Hillhouse Investment, and Gaorong Ventures. Axoft plans to use these funds to expand its global clinical trials and advance the U.S. regulatory approval of its implantable Brain-Computer Interfaces (iBCIs), aiming to enhance the interface between the brain and electronics.
Customer service technology is also a hot area, with San Francisco-based Netomi announcing an impressive $110 million in funding. This round was spearheaded by Accenture Ventures and included investments from Adobe Ventures, WndrCo, SLW, NAVER Ventures, Metis Strategy, and Fin Capital. Accenture has also entered into a global alliance with Netomi to deploy its agentic CX platform for enterprise clients worldwide.
Meanwhile, the AI-driven startup ecosystem continues its strong performance, building on a record-breaking first quarter of 2026. Globally, venture investment in Q1 2026 reached an unprecedented $300 billion, with AI companies attracting a significant portion of this capital.
In other news, Hemab Therapeutics Holdings, Inc., a clinical-stage biotechnology company focused on blood coagulation disorders, has priced its initial public offering (IPO). The company expects to raise approximately $301.5 million and its shares are set to begin trading on the Nasdaq Global Select Market today under the ticker symbol “COAG.”
On the academic innovation front, Vatsal Pandya, nearing graduation from the University of Nebraska–Lincoln, has launched his AI venture, TasksMind. The company aims to reduce on-call demand and fatigue among software engineers using artificial intelligence. Pandya, along with co-founders Kashish Syed and Thang Do, will relocate to San Francisco to further develop the startup.
In the space sector, BioOrbit has raised £9.8 million in seed funding to support its mission of manufacturing cancer drugs in orbit. The company plans to expand its production capabilities and open an office on the East Coast of the U.S., with former Redwire executives joining its leadership.
Elsewhere, the Startup Moldova Summit 2026 highlighted the nation's growing appeal as a startup hub for European markets, attracting over 2,000 participants and announcing new international partnerships to bolster its ecosystem.
Forbes has also opened nominations for its 2026 Next Billion-Dollar Startups list, seeking innovative companies with significant growth potential, with submissions due by May 1, 2026.